ELGOZON 200MG Tablet contains Elagolix 200mg, a prescription hormonal medicine belonging to the gonadotropin-releasing hormone (GnRH) receptor antagonist class. Elagolix works by reducing the hormonal signals that stimulate ovarian estrogen production.
Elagolix may be prescribed for the management of endometriosis-associated pain and other approved gynecological conditions, depending on the specific product labeling and medical assessment. By lowering estrogen levels, ELGOZON may help reduce hormonal stimulation of endometrial tissue and relieve symptoms associated with endometriosis.
Because Elagolix affects reproductive hormones, menstrual bleeding, bone mineral density, and fertility, treatment should be used under the supervision of a qualified healthcare professional.
ELGOZON 200MG is supplied as an oral tablet by Horizon Pharma, according to the provided product information.
Elagolix may help reduce pain associated with endometriosis by lowering ovarian estrogen activity.
ELGOZON reduces hormonal stimulation of the ovaries, resulting in lower circulating estrogen levels.
Elagolix directly blocks GnRH receptors in the pituitary gland and reduces the release of LH and FSH.
Reduced estrogen exposure can decrease stimulation of endometrial tissue and may help improve endometriosis-related symptoms.
ELGOZON 200MG provides an oral treatment option for patients prescribed Elagolix therapy.
The dose and duration of treatment should be determined by a healthcare professional based on the patient's condition and risk factors.
ELGOZON 200MG Tablet is listed under Horizon Pharma according to the supplied product details.
ELGOZON contains Elagolix, a selective GnRH receptor antagonist.
Normally, GnRH stimulates the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These hormones stimulate the ovaries and contribute to estrogen production.
Elagolix blocks GnRH receptors in the pituitary gland. This decreases LH and FSH stimulation of the ovaries and consequently lowers estrogen levels.
Lower estrogen levels can reduce hormonal stimulation of endometrial tissue and may help relieve endometriosis-associated pain.
The degree of estrogen suppression depends on the prescribed Elagolix dose.
Elagolix may be prescribed for approved gynecological conditions such as:
The 200mg strength may be selected in treatment situations where a greater degree of ovarian hormone suppression is required.
Always follow the indication and dosing instructions provided by your gynecologist or healthcare professional.
ELGOZON may be considered for adult women who:
Elagolix is not suitable for everyone. Your doctor may consider your liver function, bone health, reproductive plans, menstrual history, other medical conditions, and current medicines before prescribing ELGOZON.
| Active Ingredient | Strength | Function |
|---|---|---|
| Elagolix | 200mg | GnRH receptor antagonist that reduces ovarian hormonal stimulation and estrogen production |
Take ELGOZON exactly as prescribed by your doctor.
General administration guidance includes:
The appropriate Elagolix regimen can vary according to the medical indication, liver function, other medicines, and individual risk factors.
Do not self-adjust the dose.
Elagolix treatment is generally subject to duration limitations because prolonged estrogen suppression can reduce bone mineral density.
The recommended duration can vary according to the strength used and the medical indication.
Your healthcare provider will determine how long ELGOZON should be used based on your symptoms, treatment response, bone-health risk, liver function, and other factors.
If you miss a dose, follow the missed-dose instructions provided by your healthcare professional or the product information.
Do not take two tablets together to compensate for a missed dose unless specifically instructed by your doctor.
Like all medicines, ELGOZON 200MG may cause side effects, although not everyone experiences them.
The frequency and severity of side effects can vary between individuals.
Because Elagolix lowers estrogen levels, treatment can lead to a decrease in bone mineral density.
Patients with existing osteoporosis or other fracture risk factors may require additional evaluation before treatment.
Contact your healthcare provider promptly if you develop concerning or persistent symptoms.
Before taking ELGOZON 200MG, tell your doctor if you:
Your healthcare provider may evaluate liver function, bone-health risk, and other factors before and during treatment.
Elagolix may affect liver enzymes in some patients.
Tell your doctor if you have liver disease or a history of abnormal liver tests. Depending on liver function, Elagolix may require adjustment or may not be appropriate.
Seek medical advice if you develop possible symptoms of liver problems, including:
Estrogen plays an important role in maintaining bone strength.
Because ELGOZON reduces estrogen levels, prolonged treatment may decrease bone mineral density. This may be particularly important for patients who already have low bone density or other osteoporosis risk factors.
Tell your healthcare provider if you have:
Your doctor will determine whether ELGOZON is appropriate and whether bone-health monitoring is needed.
ELGOZON may change menstrual bleeding. Some women may experience lighter periods, irregular bleeding, or absent menstrual periods during treatment.
Because these changes can make pregnancy more difficult to recognize from menstrual patterns alone, contact your healthcare provider if pregnancy is suspected.
Elagolix can reduce ovulation but should not be relied upon as a contraceptive.
If pregnancy is not desired, discuss appropriate non-hormonal or other suitable contraception with your healthcare provider.
Tell your doctor or pharmacist about all medicines and supplements you are taking.
Potentially important interactions may involve:
Some medicines can alter Elagolix concentrations and may affect its safety or effectiveness.
Do not start, stop, or change another medicine without professional medical advice.
ELGOZON should not be used during pregnancy.
Elagolix may affect reproductive hormones and can make menstrual changes that complicate recognition of pregnancy.
If you become pregnant while taking ELGOZON, contact your healthcare provider promptly.
If you are breastfeeding or planning to breastfeed, discuss the potential benefits and risks of Elagolix treatment with your doctor.
ELGOZON may cause dizziness, sleep disturbances, mood changes, or other symptoms in some patients.
If you experience dizziness or any effect that reduces alertness or concentration, use caution when driving or operating machinery.
Contains Elagolix 200mg, a GnRH receptor antagonist used for approved hormone-dependent gynecological conditions.
Works at GnRH receptors to reduce pituitary hormonal signaling and ovarian estrogen production.
Provides a convenient oral treatment option when Elagolix therapy is prescribed.
Treatment should be based on professional medical assessment because Elagolix can affect bone health, liver function, menstrual bleeding, and reproductive hormones.
ELGOZON 200MG Tablet is listed under Horizon Pharma according to the supplied product information.
Sample/Placeholder Reviews – for demonstration only
⭐⭐⭐⭐⭐ Ayesha K. – Lahore
"SuperCare Pharma made the ordering process easy, and the medicine was delivered securely."
⭐⭐⭐⭐⭐ Sana M. – Karachi
"Convenient online ordering and the package arrived safely and properly packed."
⭐⭐⭐⭐⭐ Hira S. – Islamabad
"Good ordering experience with secure packaging and convenient delivery."
| Product Information | Details |
|---|---|
| Brand | HORIZON PHARMA |
| Product Name | ELGOZON 200MG TABLET |
| Generic | Elagolix |
| Strength | 200mg |
| Dosage Form | Tablet |
| Pack Size | 14 Tablets |
| Medicine Type | Prescription Medicine |
| Drug Class | GnRH Receptor Antagonist |
| Primary Use | Management of approved hormone-dependent gynecological conditions, including endometriosis-associated pain |
ELGOZON contains Elagolix 200mg and may be prescribed for the management of endometriosis-associated pain and other approved gynecological conditions.
Elagolix blocks GnRH receptors, reducing LH and FSH stimulation of the ovaries and lowering estrogen production.
Yes. Elagolix can change menstrual bleeding and may cause lighter, irregular, or absent periods during treatment.
Yes. Elagolix should not be considered reliable contraception. Discuss appropriate contraceptive options with your healthcare provider.
Elagolix can affect bone mineral density, liver function, mood, menstrual bleeding, and reproductive hormones. Your healthcare provider can determine the appropriate treatment duration and monitoring based on your individual risk factors.
Choose SuperCare Pharma for a convenient online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Convenient delivery across Pakistan
✔ Carefully packed orders
✔ Competitive pricing
✔ Customer support
ELGOZON 200MG is a prescription medicine. Use it only according to the advice of a qualified healthcare professional.
Looking for ELGOZON 200MG Tablet (Elagolix 200mg) in Pakistan? Order through SuperCare Pharma for a convenient online pharmacy experience and reliable delivery.
Because Elagolix is a prescription hormonal medicine with important precautions and treatment-duration considerations, use ELGOZON only according to your healthcare provider's instructions.
